Neoleukin Therapeutics, Inc. announced resignation of Robert Ho as Corporate Secretary to pursue another opportunity, effective March 1, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.01 USD | +2.10% | +11.00% | +75.49% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+75.49% | 429M | |
+41.79% | 50.93B | |
-0.56% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.59% | 26.02B | |
-21.51% | 18.9B | |
+6.92% | 13.21B | |
+24.91% | 12.17B | |
+29.60% | 12.16B |
- Stock Market
- Equities
- NGNE Stock
- News Neurogene Inc.
- Neoleukin Therapeutics, Inc. Announces Resignation of Robert Ho as Corporate Secretary, Effective March 1, 2022